Abecma (idecabtagene vicleucel) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Aukelso (denosumab-kyqq) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to prevent bone problems, also called skeletal-related events, in people with multiple myeloma.

BiCNU (carmustine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple myeloma.

Bilprevda (denosumab-nxxp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent skeletal-related events, or serious bone problems, in people with multiple myeloma.

Blenrep (belantamab mafodotin-blmf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with relapsed or refractory multiple myeloma.

Bomyntra (denosumab-bnht) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to prevent bone problems, also called skeletal-related events, in people with multiple myeloma.

Boruzu (bortezomib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Carvykti (ciltacabtagene autoleucel) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Darzalex (daratumumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Darzalex Faspro (daratumumab and hyaluronidase-fihj) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple myeloma. It can be given by itself or with other medicines.

Doxil (doxorubicin liposomal) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Elrexfio (elranatamab-bcmm) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Empliciti (elotuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma in combination with lenalidomide and dexamethasone after one to three prior therapies, or with pomalidomide and dexamethasone after at least two prior therapies, including lenalidomide and a proteasome inhibitor.

Evomela (melphalan) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for use as a high-dose conditioning treatment before a stem cell transplant in adults with multiple myeloma.

Kyprolis (carfilzomib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma who have received earlier treatment. It may be used alone or with certain other medicines.

Lynozyfic (linvoseltamab-gcpt) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma.

Mozobil (plerixafor) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for use in adults with multiple myeloma to move stem cells into the blood for collection.